Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
4.700
-0.120 (-2.49%)
Nov 20, 2024, 4:00 PM EST - Market closed
Genenta Science Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.86 | 5.26 | 5.71 | 2.3 | 0.9 | 0.92 |
| Research & Development | 4.59 | 6.47 | 5.34 | 3.39 | 4.69 | 3.7 |
| Operating Expenses | 9.45 | 11.73 | 11.04 | 5.69 | 5.59 | 4.62 |
| Operating Income | -9.45 | -11.73 | -11.04 | -5.69 | -5.59 | -4.62 |
| Interest Expense | - | - | - | -0.01 | -0.01 | -0.01 |
| Interest & Investment Income | 0.44 | 0.31 | 0.04 | - | - | - |
| Currency Exchange Gain (Loss) | 0.09 | -0.22 | 2.29 | - | - | - |
| Other Non Operating Income (Expenses) | -0 | -0 | 0.24 | 0.02 | 0.01 | 0.04 |
| EBT Excluding Unusual Items | -8.92 | -11.65 | -8.48 | -5.68 | -5.59 | -4.6 |
| Other Unusual Items | - | - | - | 0.15 | - | - |
| Pretax Income | -8.92 | -11.65 | -8.48 | -5.53 | -5.59 | -4.6 |
| Net Income | -8.92 | -11.65 | -8.48 | -5.53 | -5.59 | -4.6 |
| Net Income to Common | -8.92 | -11.65 | -8.48 | -5.53 | -5.59 | -4.6 |
| Shares Outstanding (Basic) | 18 | 18 | 18 | 15 | 15 | 13 |
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 15 | 15 | 13 |
| Shares Change (YoY) | 0.11% | 0.00% | 20.77% | 3.74% | 14.93% | - |
| EPS (Basic) | -0.49 | -0.64 | -0.47 | -0.37 | -0.38 | -0.36 |
| EPS (Diluted) | -0.49 | -0.64 | -0.47 | -0.37 | -0.38 | -0.36 |
| Free Cash Flow | -5.69 | -11.22 | -7.45 | -6.97 | -6.07 | -2.49 |
| Free Cash Flow Per Share | -0.31 | -0.62 | -0.41 | -0.46 | -0.42 | -0.20 |
| EBITDA | -9.41 | -11.69 | -11.04 | -5.68 | -5.59 | - |
| D&A For EBITDA | 0.04 | 0.04 | 0.01 | 0 | 0 | - |
| EBIT | -9.45 | -11.73 | -11.04 | -5.69 | -5.59 | -4.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.